GLP-1 Injections and Cardiovascular Health Why Heart Health Matters in the East Valley Cardiovascular disease remains the leading cause of death in Arizona, with high rates of hypertension and metabolic syndrome among Mesa & Scottsdale residents. While GLP‑1 receptor agonists are celebrated for weight reduction, emerging evidence shows they also improve heart health by lowering blood pressure, reducing inflammation, and decreasing arterial plaque buildup. Integrating GLP‑1 therapy into your care plan can deliver dual

GLP-1 Injections – Science 1. The Biology of GLP‑1: More Than Just Appetite Control Glucagon‑like peptide‑1 (GLP‑1) is a naturally occurring gut hormone released after eating. It slows gastric emptying, stimulates insulin secretion, and signals satiety centers in the brain. By mimicking GLP‑1’s action, medications like semaglutide and tirzepatide help Scottsdale & Mesa patients feel fuller on smaller meals and achieve sustained caloric reduction. 2. Molecular Mechanism: How Semaglutide & Tirzepatide Work Unlike

GLP-1 Injections: What to Expect During Treatment 1. Beginning Your GLP-1 Treatment: What to Anticipate Embarking on a GLP-1 receptor agonist therapy, such as semaglutide (Ozempic®, Wegovy®) or tirzepatide (Mounjaro®), begins with a comprehensive consultation at New Results Medical Weight Loss. During this session, healthcare professionals assess your medical history, current health status, and weight loss objectives to determine the suitability of GLP-1 therapy for you. This personalized approach ensures that the treatment aligns with your individual